Mestag Therapeutics

Fibroblasts were once considered bystanders in disease; however, recent data shows fibroblasts can affect normal immune cell function. Using single cell technology, Mestag has identified specific pathogenic fibroblast populations that can be modulated to restore the normal innate and adaptive immune responses in cancer and inflammatory diseases.